Safety assessment reevaluation of Biotechnology-Derived Pharmaceuticals as the imperative for getting renewed Marketing Authorisation Approval (MAA) Experience from Medicies and Medical Devices Agency of Serbia-Alims

Stanimirovic, Violeta V; Nikolic, Dejan V; Nikolic, Aleksandra T; Stanimitovic, B; Stanimirovic, B

Rezultati

eNauka > Rezultati > Safety assessment reevaluation of Biotechnology-Derived Pharmaceuticals as the imperative for getting renewed Marketing Authorisation Approval (MAA) Experience from Medicies and Medical Devices Agency of Serbia-Alims

Naziv:	Safety assessment reevaluation of Biotechnology-Derived Pharmaceuticals as the imperative for getting renewed Marketing Authorisation Approval (MAA) Experience from Medicies and Medical Devices Agency of Serbia-Alims
Autori:	Stanimirovic, Violeta V; Nikolic, Dejan V; Nikolic, Aleksandra T ; Stanimitovic, B; Stanimirovic, B
Godina:	2013
Publikacija:	PROCEEDINGS OF THE 6TH EUROPEAN CONGRESS OF PHARMACOLOGY
Tip rezultata:	Konferencijski rad
Kolacija:	str. 177-180
WoS-ID:	000322821600035
URI:	https://enauka.gov.rs/handle/123456789/806891
Izvor metapodataka:	(Preuzeto iz Nasi u WoS)
M-kategorija:	Mp kategorija će biti prikazana naknadno.

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.